<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Clin Infect Dis</journal-id><journal-id journal-id-type="pmc-domain-id">1409</journal-id><journal-id journal-id-type="pmc-domain">cid</journal-id><journal-id journal-id-type="publisher-id">cid</journal-id><journal-title-group><journal-title>Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America</journal-title></journal-title-group><issn pub-type="ppub">1058-4838</issn><issn pub-type="epub">1537-6591</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10371303</article-id><article-id pub-id-type="pmcid-ver">PMC10371303.1</article-id><article-id pub-id-type="pmcaid">10371303</article-id><article-id pub-id-type="pmcaiid">10371303</article-id><article-id pub-id-type="pmid">37021689</article-id><article-id pub-id-type="doi">10.1093/cid/ciad204</article-id><article-id pub-id-type="publisher-id">ciad204</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Major Article</subject><subj-group subj-group-type="category-toc-heading"><subject>Original Article</subject></subj-group></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/MED00290</subject></subj-group></article-categories><title-group><article-title>Health Insurance and Initiation of Direct-Acting Antivirals for Hepatitis C in US Women With Human Immunodeficiency Virus</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6768-0096</contrib-id><name name-style="western"><surname>Edmonds</surname><given-names initials="A">Andrew</given-names></name><aff>
<institution>Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill</institution>, <addr-line>Chapel Hill, North Carolina</addr-line>, <country country="US">USA</country></aff><xref rid="ciad204-cor1" ref-type="corresp"/><xref rid="ciad204-FM1" ref-type="author-notes"/><xref rid="ciad204-FM2" ref-type="author-notes"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Haley</surname><given-names initials="DF">Danielle F</given-names></name><aff>
<institution>Department of Community Health Sciences, Boston University School of Public Health</institution>, <addr-line>Boston, Massachusetts</addr-line>, <country country="US">USA</country></aff><xref rid="ciad204-FM1" ref-type="author-notes"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Edwards</surname><given-names initials="JK">Jessie K</given-names></name><aff>
<institution>Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill</institution>, <addr-line>Chapel Hill, North Carolina</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ramirez</surname><given-names initials="C">Catalina</given-names></name><aff>
<institution>Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill</institution>, <addr-line>Chapel Hill, North Carolina</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>French</surname><given-names initials="AL">Audrey L</given-names></name><aff>
<institution>Division of Infectious Diseases, Stroger (Cook County) Hospital</institution>, <addr-line>Chicago, Illinois</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tien</surname><given-names initials="PC">Phyllis C</given-names></name><aff>
<institution>Department of Medicine, University of California&#8211;San Francisco, and San Francisco Veterans Affairs Health Care System</institution>, <addr-line>San Francisco, California</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4554-7483</contrib-id><name name-style="western"><surname>Plankey</surname><given-names initials="M">Michael</given-names></name><aff>
<institution>Department of Medicine, Georgetown University Medical Center</institution>, <addr-line>Washington, DC</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sharma</surname><given-names initials="A">Anjali</given-names></name><aff>
<institution>Department of Medicine, Albert Einstein College of Medicine</institution>, <addr-line>Bronx, New York</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Augenbraun</surname><given-names initials="M">Michael</given-names></name><aff>
<institution>Division of Infectious Diseases, Department of Medicine, State University of New York Downstate Health Sciences University</institution>, <addr-line>Brooklyn, New York</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Seaberg</surname><given-names initials="EC">Eric C</given-names></name><aff>
<institution>Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University</institution>, <addr-line>Baltimore, Maryland</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9918-9493</contrib-id><name name-style="western"><surname>Workowski</surname><given-names initials="K">Kimberly</given-names></name><aff>
<institution>Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine</institution>, <addr-line>Atlanta, Georgia</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alcaide</surname><given-names initials="ML">Maria L</given-names></name><aff>
<institution>Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine</institution>, <addr-line>Miami, Florida</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Albrecht</surname><given-names initials="S">Svenja</given-names></name><aff>
<institution>Division of Infectious Diseases, Department of Medicine, University of Mississippi Medical Center</institution>, <addr-line>Jackson, Mississippi</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Adimora</surname><given-names initials="AA">Adaora A</given-names></name><aff>
<institution>Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill</institution>, <addr-line>Chapel Hill, North Carolina</addr-line>, <country country="US">USA</country></aff><aff>
<institution>Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill</institution>, <addr-line>Chapel Hill, North Carolina</addr-line>, <country country="US">USA</country></aff><xref rid="ciad204-FM10" ref-type="author-notes"/></contrib></contrib-group><author-notes><fn id="ciad204-FM1"><p>A. E., D. F. H. contributed equally to this work and serve as co-primary authors.</p></fn><fn id="ciad204-FM2"><p>Presented in part: 2020 Conference on Retroviruses and Opportunistic Infections, Boston, MA, 8&#8211;11 March 2020 (abstract 00568).</p></fn><corresp id="ciad204-cor1">Correspondence: A. Edmonds, Department of Epidemiology, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, 123 W. Franklin St, Ste. 3211, Chapel Hill, NC 27516 (<email>aedmonds@email.unc.edu</email>).</corresp><fn id="ciad204-FM10" fn-type="COI-statement"><p>
<bold>
<italic toggle="yes">Potential conflicts of interest</italic>.</bold> A. A. A. reports consultancies with Merck and Gilead, royalties or licenses from Gilead related to consultations, research funding from Merck and Gilead, and nonfinancial interests from roles on the Infectious Diseases Society of America Board of Directors and IAS Governing Council. M. L. A. reports consultancies with Gilead; payment or honoraria from Gilead, Merck, and Discidium Biosciences (paid to author); travel support from Merck; participation on a data and safety monitoring board or advisory board for Senhwa Biosciences; and research funding from AbbVie and NIH. A. S. reports research funding and payment for participation in advisory board meetings from Gilead. P. C. T. reports research funding from Merck, Gilead, and Eli-Lilly (all paid to institution); royalties or licenses from UptoDate (paid to author); honorarium from Vindico CME; and participation on the STAR cohort Scientific Advisory Board and BIRCWH K12 External Scientific Advisory Board. K. W. reports research funding from AbbVie. C. R. reports grants and travel support from NIH (paid to institution). M. P. reports travel/meeting support from NIH (to the author's institution). A. L. F. reports travel support from NIH. J. K. E. reports institutional grants from NIH NIGMS and travel support from the Society for Epidemiologic Research (paid to author). D. F. H. reports additional NIDA salary support as a co-investigator. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.</p></fn></author-notes><pub-date pub-type="collection"><day>15</day><month>7</month><year>2023</year></pub-date><pub-date pub-type="epub" iso-8601-date="2023-04-06"><day>06</day><month>4</month><year>2023</year></pub-date><volume>77</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">441641</issue-id><fpage>258</fpage><lpage>264</lpage><history><date date-type="received"><day>23</day><month>1</month><year>2023</year></date><date date-type="editorial-decision"><day>02</day><month>4</month><year>2023</year></date><date date-type="corrected-typeset"><day>13</day><month>5</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>06</day><month>04</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>06</day><month>04</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-04-06 00:25:12.813"><day>06</day><month>04</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref>https://academic.oup.com/pages/standard-publication-reuse-rights</ali:license_ref><license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://academic.oup.com/pages/standard-publication-reuse-rights">https://academic.oup.com/pages/standard-publication-reuse-rights</ext-link>)</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="ciad204.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ciad204.pdf"/><abstract><title>Abstract</title><sec id="s1"><title>Background</title><p>Direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) is well tolerated, cost-effective, and yields high sustained virologic response rates, yet it has remained financially inaccessible to many patients.</p></sec><sec id="s2"><title>Methods</title><p>Participants of the Women's Interagency HIV Study (an observational US cohort) with human immunodeficiency virus (HIV) and HCV (RNA+) reporting no prior hepatitis C treatment were followed for DAA initiation (2015&#8211;2019). We estimated risk ratios (RRs) of the relationship between time-varying health insurance status and DAA initiation, adjusting for confounders with stabilized inverse probability weights. We also estimated weighted cumulative incidences of DAA initiation by health insurance status.</p></sec><sec id="s3"><title>Results</title><p>A total of 139 women (74% Black) were included; at baseline, the median age was 55 years and 86% were insured. Most had annual household incomes &#8804;$18 000 (85%); advanced liver fibrosis (21%), alcohol use (45%), and recreational drug use (35%) were common. Across 439 subsequent semiannual visits, 88 women (63%) reported DAA initiation. Compared with no health insurance, health insurance increased the likelihood of reporting DAA initiation at a given visit (RR, 4.94; 95% confidence limit [CL], 1.92 to 12.8). At 2 years, the weighted cumulative incidence of DAA initiation was higher among the insured (51.2%; 95% CL, 43.3% to 60.6%) than the uninsured (3.5%; 95% CL, 0.8% to 14.6%).</p></sec><sec id="s4"><title>Conclusions</title><p>Accounting for clinical, behavioral, and sociodemographic factors over time, health insurance had a substantial positive effect on DAA initiation. Interventions to increase insurance coverage should be prioritized to increase HCV curative therapy uptake for persons with HIV.</p></sec></abstract><abstract abstract-type="teaser"><p>Among US women with human immunodeficiency virus and hepatitis C virus, health insurance had a substantial positive effect on the initiation of direct-acting antiviral therapy.</p></abstract><kwd-group><kwd>direct-acting antivirals</kwd><kwd>health insurance</kwd><kwd>hepatitis C</kwd><kwd>HIV</kwd><kwd>women</kwd></kwd-group><funding-group><award-group award-type="grant"><funding-source><institution-wrap><institution>National Institute on Aging</institution><institution-id institution-id-type="DOI">10.13039/100000049</institution-id></institution-wrap></funding-source></award-group><award-group award-type="grant"><funding-source><institution-wrap><institution>National Institute of Allergy and Infectious Diseases</institution><institution-id institution-id-type="DOI">10.13039/100000060</institution-id></institution-wrap></funding-source></award-group><award-group award-type="grant"><funding-source><institution-wrap><institution>National Institute of Neurological Disorders and Stroke</institution><institution-id institution-id-type="DOI">10.13039/100000065</institution-id></institution-wrap></funding-source></award-group><award-group award-type="grant"><funding-source><institution-wrap><institution>National Institute of Mental Health</institution><institution-id institution-id-type="DOI">10.13039/100000025</institution-id></institution-wrap></funding-source></award-group><award-group award-type="grant"><funding-source><institution-wrap><institution>National Institute on Drug Abuse</institution><institution-id institution-id-type="DOI">10.13039/100000026</institution-id></institution-wrap></funding-source></award-group><award-group award-type="grant"><funding-source><institution-wrap><institution>National Cancer Institute</institution><institution-id institution-id-type="DOI">10.13039/100000054</institution-id></institution-wrap></funding-source></award-group><award-group award-type="grant"><funding-source><institution-wrap><institution>National Institute on Deafness and Other Communication Disorders</institution><institution-id institution-id-type="DOI">10.13039/100000055</institution-id></institution-wrap></funding-source></award-group><award-group award-type="grant"><funding-source><institution-wrap><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution><institution-id institution-id-type="DOI">10.13039/100000062</institution-id></institution-wrap></funding-source></award-group><award-group award-type="grant"><funding-source><institution-wrap><institution>National Institute on Minority Health and Health Disparities</institution><institution-id institution-id-type="DOI">10.13039/100006545</institution-id></institution-wrap></funding-source></award-group><award-group award-type="grant"><funding-source><institution-wrap><institution>Office of AIDS Research</institution><institution-id institution-id-type="DOI">10.13039/100006084</institution-id></institution-wrap></funding-source><award-id>UL1-TR000004</award-id><award-id>UL1-TR003098</award-id><award-id>UL1-TR001881</award-id><award-id>P30-AI-050409</award-id><award-id>P30-AI-073961</award-id><award-id>P30-AI-050410</award-id><award-id>P30-AI-027767</award-id><award-id>P30-MH-116867</award-id><award-id>UL1-TR001409</award-id><award-id>KL2-TR001432</award-id><award-id>TL1-TR001431</award-id><award-id>R01AI157758</award-id><award-id>K01DA046307</award-id></award-group><award-group award-type="grant"><funding-source><institution-wrap><institution>Johns Hopkins University</institution><institution-id institution-id-type="DOI">10.13039/100007880</institution-id></institution-wrap></funding-source><award-id>P30-AI-094189</award-id></award-group></funding-group><counts><page-count count="7"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>